Have Insiders Sold LeMaitre Vascular Shares Recently?

We wouldn't blame LeMaitre Vascular, Inc. (NASDAQ:LMAT) shareholders if they were a little worried about the fact that George LeMaitre, the Chairman & CEO recently netted about US$8.2m selling shares at an average price of US$85.59. However, it's crucial to note that they remain very much invested in the stock and that sale only reduced their holding by 5.0%.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

LeMaitre Vascular Insider Transactions Over The Last Year

Notably, that recent sale by George LeMaitre is the biggest insider sale of LeMaitre Vascular shares that we've seen in the last year. So what is clear is that an insider saw fit to sell at around the current price of US$81.50. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. We note that this sale took place at around the current price, so it isn't a major concern, though it's hardly a good sign.

In the last year LeMaitre Vascular insiders didn't buy any company stock. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. By clicking on the graph below, you can see the precise details of each insider transaction!

Check out our latest analysis for LeMaitre Vascular

I will like LeMaitre Vascular better if I see some big insider buys. While we wait, check out this free list of undervalued and small cap stocks with considerable, recent, insider buying.

Insider Ownership Of LeMaitre Vascular

Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It's great to see that LeMaitre Vascular insiders own 8.8% of the company, worth about US$163m. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

So What Does This Data Suggest About LeMaitre Vascular Insiders?

Insiders sold stock recently, but they haven't been buying. And there weren't any purchases to give us comfort, over the last year. But it is good to see that LeMaitre Vascular is growing earnings. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. You'd be interested to know, that we found 1 warning sign for LeMaitre Vascular and we suggest you have a look.

But note: LeMaitre Vascular may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.